The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides
India’s largest life sciences entrepreneurship competition opens applications for startups, innovators and student teams nationwide
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
The agreement brings to market a method pioneered at CU Boulder that enables the reliable synthesis of long RNA strands
A dedicated Life Sciences Innovation Fund, scalable up to Rs. 1,000 crore, will catalyze early- and growth-stage innovation, support deep-tech ventures – particularly biotherapeutics
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
Infections with H. pylori affect over 43 percent of the world’s population with a wide range of gastrointestinal disorders
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
